CeriBell, Inc. CBLL

CBLL Company Overview

CeriBell, Inc. is a medical technology company focused on neurodiagnostics and critical care monitoring. The company develops artificial intelligence-enabled electroencephalography (EEG) systems designed to improve the speed and accessibility of neurological assessment in acute care settings. CeriBell primarily operates within the medical device, digital health, and neurocritical care industries, with its products aimed at hospitals, emergency departments, intensive care units, and other clinical environments where rapid neurological evaluation is required.

The company’s primary commercial platform is the Ceribell System, which combines a portable EEG headband, recorder hardware, cloud-connected software, and machine learning-based seizure detection tools. Its revenue is primarily generated through sales and usage of its EEG systems, disposable components, software-enabled services, and associated hospital contracts. CeriBell positions itself as a provider of rapid-response EEG technology intended to reduce delays associated with conventional EEG testing, which historically required specialized technicians and neurologists. Founded in 2014, the company evolved from an academic and clinical effort to simplify EEG deployment and expand neurological monitoring access beyond specialized epilepsy centers into broader emergency and critical care settings.